COVID-19 and Hyperglycemia/diabetes

Overview

Journal World J Diabetes

Publisher Baishideng Publishing Group

Specialty Endocrinology

Date 2021 May 17

PMID 33995851

Citations 11

Authors

Konstantinos Michalakis

Ioannis Ilias

Affiliations

Soon will be listed here.

Abstract

In early studies regarding coronavirus disease 2019 (COVID-19), type 2 diabetes mellitus was considered to contribute substantially to the disease's inflammatory response. Subsequently, even hyperglycemia, regardless of insulin resistance or diabetes mellitus, was found to be additionally harmful. Recent studies have shown inflammation of the pancreatic β cells in COVID-19, even leading to new onset diabetes mellitus. We hereby summarize core literature on glycemia and COVID-19, and present implicated pathways and mechanisms.

Citing Articles

A multicenter, real-world cohort study: effectiveness and safety of Azvudine in hospitalized COVID-19 patients with pre-existing diabetes.

Zhou Y, Yang Z, Zhang S, Zhang D, Luo H, Zhu D Front Endocrinol (Lausanne). 2025; 16:1467303.

PMID: 40046873 PMC: 11879813. DOI: 10.3389/fendo.2025.1467303.

Impact of Hyponatremia on COVID-19-Related Outcomes: A Retrospective Analysis.

Piza P, de Freitas V, Aguiar-Brito I, Calsolari-Oliveira B, Rangel E Biomedicines. 2024; 12(9).

PMID: 39335510 PMC: 11444129. DOI: 10.3390/biomedicines12091997.

Mechanisms of long COVID and the path toward therapeutics.

Peluso M, Deeks S Cell. 2024; 187(20):5500-5529.

PMID: 39326415 PMC: 11455603. DOI: 10.1016/j.cell.2024.07.054.

Prevalence and short-term clinical impacts of new-onset diabetes mellitus among patients with COVID-19 in jazan region, Saudi Arabia.

Mohamed A, Darraj M, Yassin A, Somaili M, Sayed A, Oraibi O BMC Endocr Disord. 2024; 24(1):197.

PMID: 39304825 PMC: 11414278. DOI: 10.1186/s12902-024-01724-z.

The changing trend of fungal infection in invasive rhinosinusitis in the COVID era.

Garg P, Ranjan V, Avnisha , Hembrom S, Goel S, Malhotra S J Family Med Prim Care. 2024; 13(4):1428-1433.

PMID: 38827671 PMC: 11141948. DOI: 10.4103/jfmpc.jfmpc_871_23.

References

Michalakis K, Panagiotou G, Ilias I, Pazaitou-Panayiotou K . Obesity and COVID-19: A jigsaw puzzle with still missing pieces. Clin Obes. 2020; 11(1):e12420. PMC: 7645965. DOI: 10.1111/cob.12420. View

Zeng Z, Yu H, Chen H, Qi W, Chen L, Chen G . Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China. Crit Care. 2020; 24(1):525. PMC: 7450961. DOI: 10.1186/s13054-020-03255-0. View

Underwood P, Adler G . The renin angiotensin aldosterone system and insulin resistance in humans. Curr Hypertens Rep. 2012; 15(1):59-70. PMC: 3551270. DOI: 10.1007/s11906-012-0323-2. View

Boni-Schnetzler M, Meier D . Islet inflammation in type 2 diabetes. Semin Immunopathol. 2019; 41(4):501-513. PMC: 6592966. DOI: 10.1007/s00281-019-00745-4. View

Ilias I, Jahaj E, Kokkoris S, Zervakis D, Temperikidis P, Magira E . Clinical Study of Hyperglycemia and SARS-CoV-2 Infection in Intensive Care Unit Patients. In Vivo. 2020; 34(5):3029-3032. PMC: 7652529. DOI: 10.21873/invivo.12136. View

Wu L, Girgis C, Cheung N . COVID-19 and diabetes: Insulin requirements parallel illness severity in critically unwell patients. Clin Endocrinol (Oxf). 2020; 93(4):390-393. PMC: 7404426. DOI: 10.1111/cen.14288. View

Fadini G, Morieri M, Boscari F, Fioretto P, Maran A, Busetto L . Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration. Diabetes Res Clin Pract. 2020; 168:108374. PMC: 7428425. DOI: 10.1016/j.diabres.2020.108374. View

Ismaila M, Bande F, Ishaka A, Sani A, Georges K . Therapeutic options for COVID-19: a quick review. J Chemother. 2021; 33(2):67-84. DOI: 10.1080/1120009X.2020.1868237. View

Tortajada C, Colomer E, Andreu-Ballester J, Esparcia A, Oltra C, Flores J . Corticosteroids for COVID-19 patients requiring oxygen support? Yes, but not for everyone: Effect of corticosteroids on mortality and intensive care unit admission in patients with COVID-19 according to patients' oxygen requirements. J Med Virol. 2020; 93(3):1817-1823. DOI: 10.1002/jmv.26635. View

10.

Holman N, Knighton P, Kar P, OKeefe J, Curley M, Weaver A . Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2020; 8(10):823-833. PMC: 7426091. DOI: 10.1016/S2213-8587(20)30271-0. View

11.

Coppelli A, Giannarelli R, Aragona M, Penno G, Falcone M, Tiseo G . Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study. Diabetes Care. 2020; 43(10):2345-2348. DOI: 10.2337/dc20-1380. View

12.

Miklowski M, Jansen B, Auron M, Whinney C . The hospitalized patient with COVID-19 on the medical ward: Cleveland Clinic approach to management. Cleve Clin J Med. 2020; . DOI: 10.3949/ccjm.87a.ccc064. View

13.

Wang S, Ma P, Zhang S, Song S, Wang Z, Ma Y . Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study. Diabetologia. 2020; 63(10):2102-2111. PMC: 7347402. DOI: 10.1007/s00125-020-05209-1. View

14.

. 2. Classification and Diagnosis of Diabetes: . Diabetes Care. 2019; 43(Suppl 1):S14-S31. DOI: 10.2337/dc20-S002. View

15.

Michalakis K, Ilias I . SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects. Diabetes Metab Syndr. 2020; 14(4):469-471. PMC: 7189186. DOI: 10.1016/j.dsx.2020.04.033. View

16.

Ebekozien O, Agarwal S, Noor N, Albanese-ONeill A, Wong J, Seeherunvong T . Inequities in Diabetic Ketoacidosis Among Patients With Type 1 Diabetes and COVID-19: Data From 52 US Clinical Centers. J Clin Endocrinol Metab. 2021; 106(4):e1755-e1762. PMC: 7928931. DOI: 10.1210/clinem/dgaa920. View

17.

Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A . Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020; 323(16):1574-1581. PMC: 7136855. DOI: 10.1001/jama.2020.5394. View

18.

Fadini G, Morieri M, Longato E, Avogaro A . Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Invest. 2020; 43(6):867-869. PMC: 7103097. DOI: 10.1007/s40618-020-01236-2. View

19.

Ilias I, Diamantopoulos A, Pratikaki M, Botoula E, Jahaj E, Athanasiou N . Glycemia, Beta-Cell Function and Sensitivity to Insulin in Mildly to Critically Ill Covid-19 Patients. Medicina (Kaunas). 2021; 57(1). PMC: 7828687. DOI: 10.3390/medicina57010068. View

20.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View